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http://dx.doi.org/10.1016/j.jds.2013.0Abstract Background/purpose: The use of membrane in preventing soft tissue ingrowth dur-
ing guided bone regeneration (GBR) procedure for better clinical results is controversial. The
present study compares and analyzes the clinical results of GBR using the autogenous tooth
bone graft (AutoBT; Korea Tooth Bank Co., Seoul, Korea) material with and without the resorb-
able membrane (Bio-Arm, ACE Surgical. Supply Company, Inc., USA).
Materials and methods: Patients who received dental implants with simultaneous GBR from
the same clinician at the Dental Department of Seoul National University Bundang Hospital
from March 2009 to May 2012 were selected in this study. A total of 20 patients with a total
number of 30 dental implants were included in this study. The patients who received GBR with
resorbable membrane were in Group 1 and those without membrane were in Group 2. AutoBT
was grafted in all patients. In each group, pre- and postoperative bone loss, regeneration in
percentage (%), and complications were evaluated.
Results: There was no statistically significant difference in pre- and postoperative reduction of
bone defect height, bone level change, and bone regeneration in percentage (%) between the
two groups (P > 0.05).nal University Bundang Hospital, Department of Oral and Maxillofacial Surgery, Section of Dentistry,
m City 463-802, Gyunggi-do, South Korea.
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3.001
282 J.-Y. Lee et alConclusion: Both groups showed clinically acceptable bone regeneration without any eventful
complications. Within the limitation of this study, we can carefully conclude that the use of
resorbable membrane is not a critical factor in GBR when using AutoBT.
Copyright ª 2013, Association for Dental Sciences of the Republic of China. Published by Else-
vier Taiwan LLC. All rights reserved.Table 1 Implant distributions: appropriate implants were
placed with proper length (ranging from 5 mm to 13 mm)
and width (ranging from 4 mm to 6 mm) according to pa-
tients’ needs.
Group 1 Group 2
Superlinea 5 8
Zimmerb 1 1
GSIIIc 4 4
CMId 3 1 (Excluded)
TSIII (SA)c 3 0
Total 16 14
Length (mm)
5 2 0
7 2 0
8 2 6
8.5 0 1
10 7 3Introduction
Guided bone regeneration (GBR) is widely employed to
overcome insufficient bone quantity and anatomical prob-
lems. During the procedure, the need of a membrane has
been a question to many clinicians. The use of a membrane
in GBR is thought to be advantageous, achieving mechanical
stabilization and preventing micromovement of the bone
graft material.1
Although resorbable membranes are widely used as they
do not need to be removed after placement, it is known that
removal is nearly impossible when the membrane is only
partially resorbed and that there can be giant cell reactions
during the process of resorption.2,3 Moreover, the early
exposure of the membrane necessitates frequent post-
operative observation followed by potential additional fees.
In contrast, there are reports showing no significant differ-
ence in bone regeneration when groups of with and without
membranes were compared with intact periosteum.3,4
Choosing the appropriate bone graft material in GBR is
challenging. Choosing the graft material needs to be
dictated by the size of the bone defects and the purpose of
procedures. In search of near ideal bone graft material, Kim
et al developed an autogenous tooth bone graft material
(AutoBT; Korea Tooth Bank Co., Seoul, Korea) from patient’s
own extracted teeth. AutoBT consists of inorganic compo-
nents, such as low-crystalline hydroxylapatite, tricalcium
phosphate, amorphous calcium phosphate, and octacalcium
phosphate.5 With inorganic and organic components, such as
noncollagenous proteins, AutoBT showed potential osteo-
conductivity and osteoinductivity.6 Moreover, the safety and
biocompatibility of AutoBT was reflected in a clinical study
with quick postoperative bone healing.7
There have been numerous reports that compare the
needs of membranes in GBR. However, this is the first study
that compared and evaluated the clinical results of GBRusing
AutoBT with and without resorbable collagen membrane
when implants were exposed at the time of second surgery.11.5 3 0
12 0 1
13 0 3
Total 16 14
Width (mm)
4 3 1
4.5 2 2
4.7 1 0
5 8 9
6 2 2
Total 16 14
a Superline (Dentium, Seoul, Korea).
b Zimmer (Zimmer Dental Inc., Carlsbad California, USA).
c GS III, TS III (OSSTEM, Busan, Korea).
d CMI (Neobiotech, Seoul, Korea).Materials and methods
Patient selection
Patients who received dental implants with simultaneous
GBR from the same examiner at the Dental Department of
Seoul National University Bundang Hospital from March
2009 to May 2012 were included in the study. Following the
approval from institutional review board of Seoul National
University Bundang Hospital (IRB No.: B-1210-176-111), the
study progressed. As a result, a total of 30 implants
were placed in 20 patients who met the inclusion criteria
(Table 1). Seven patients had controlled systemicconditions such as diabetes mellitus, hypertension, liver
problem, and cardiac problem.
Inclusion criteria
(1) Vertical dehiscence bony defects of greater than 1 mm
and less than 8 mm after implant placement, which
were grafted with particulate AutoBT only for GBR,
were included.
(2) Smoking and parafunctional habits were not assessed.
(3) Patients with controlled systemic diseases were
included in the study.
Patient distribution
Patients who received GBR with resorbable collagen mem-
brane were placed in Group 1 and without membrane were
in Group 2. Group 1 consisted of 8 patients (7 males, 1 fe-
male), and 12 patients (8 males, 4 females) were included
Table 2 Patient and intervention characteristics: 30 im-
plants were placed in a total of 20 patients in the present
study with a mean age of 49 years in Group 1 and 57 years in
Group 2.
Group 1 Group 2
Female 1 4
Male 7 8
Total no. of patients 8 12
Implant in maxilla 3 6
Implant in mandible 13 8
Total no. of implants 16 14
Mean age in years at the time
of implant insertion (range)
49.88
(26e68)
57.00
(34e77)
Month from implant placement
to exposure (range)
3.6 (2e7) 2.65 (1e4)
Figure 2 The implant is placed on a missing #36 area. Ver-
tical bone defects are measured in buccal (3 mm), lingual
(3 mm), mesial (6 mm), and distal (5 mm).
Comparative analysis of guided bone regeneration 283in Group 2. In Group 1, a total of 16 implants were placed,
three in the maxilla and 13 in the mandible. In Group 2,
among the total of 14 implants placed, six were in the
maxilla and eight were in the mandible. The average age of
Group1 was 49.8 years (range: 26-68 years old) and Group 2
was 57.0 years (range: 34-77 years old) (Table 2).Surgical procedures
Patients were presurgically prepared with 0.1% chlorhexi-
dine oral rinse for 1 minute. For two patients with cardiac
conditions, a preoperative prophylactic antibiotic (amoxi-
cillin 2 g) was prescribed. Implants were placed employing
the routinely practiced surgical methods after the elevation
of full thickness mucoperiosteal flap in both groups (Figs. 1
and 2). Peri-implant vertical bony defects were measured
at mesial, distal, buccal, and lingual sites using the peri-
odontal probe. In Group 1, resorbable collagen membrane
(Bio-Arm, ACE Surgical. Supply Company, Inc., USA) covered
AutoBT grafted site followed by the closure with 4-0 VicrylsFigure 1 The implant is placed on a missing #36 area. Ver-
tical bone defects are measured in buccal (5 mm), lingual
(4 mm), and distal (5 mm).(Ethicon Inc., Sommerville, NJ, USA) (Fig. 3). In Group 2, only
AutoBT was grafted at the defected sites (Fig. 4). Post-
operative prescriptions included antibiotics and digestives
for 5 days and chlorhexidine oral rinse for 7 days. The sec-
ondary exposure time was decided solely by the clinician
during the implant placement surgery. The decision was
depended upon the initial implant stability and the size of
bony defects at the time of the first surgery (Table 2). During
the second surgery, the flap design was identical to the first
surgery and the bone measurements were taken at the
identical sites using the same method (Figs. 5 and 6). The
implant stability was measured by using Osstell Mentor
(Integration Diagnostics AB, Goteborg, Sweden). The pri-
mary stability was measured immediately after the first
surgery. The secondary stability was measured following the
certain period of healing at the time of second surgery.Bone defect evaluation method
Bone defect height was evaluated using the average value
of the minimal vertical depth (NL) and the maximal vertical
depth (ML) (Fig. 7).Figure 3 Bone defect is filled with AutoBT and covered with
collagen membrane (Bio-Gide).
Figure 4 Bone defects are filled with AutoBT only. Figure 6 Implanted site is exposed after 9 weeks and clinical
bone defects are filled with new bone in group 2.
284 J.-Y. Lee et al% defect height reduction
Zððpreoperative bone levelðbaselineÞ
 bone defect at surgical exposure in the 2nd surgeryÞ=
preoperative bone levelðbaselineÞÞ  100
Statistical analysis
In all parameters, average and standard deviations were
calculated. An independent t test (Shapiro-Wilk test:
P > 0.05) was used in comparing the preoperative baseline
and bone level change between the two groups. Mann-
Whitney U test (Shapiro-Wilk test: P < 0.05) was employed
in comparing the bone gain (%) in accordance with the
preoperative bone level (baseline) between the groups.
Furthermore, the preoperative bone level in relation to the
bone defect at surgical exposure at the second surgery was
evaluated within each group by using the Wilcoxon signed-
rank test. All statistical analysis employed the use of SPSS
program (Ver. 12 for Windows, SPSS Inc., Chicago, IL, USA),
and the statistical significance was determined to be
P < 0.05.Figure 5 Implanted site is exposed after 9 weeks and clinical
bone defects are filled with new bone in group 1.Results
Preoperative bone level (baseline) was 2.38  0.28 mm
(Group 1) and 2.58  0.34 mm (Group 2) without any sta-
tistical significance (P > 0.05). The amount of bone defect
at surgical exposure in second surgery was 0.19  0.11 mm
(Group 1) and 0.23  0.11 mm (Group 2) showing no sta-
tistical significance (P > 0.05). The values of bone level
change in two groups were 2.19  0.32 mm (Group 1) and
2.35  0.40 mm (Group 2) (P > 0.05). Bone gain (%)
appeared to be 89.06  27.33% (Group 1), and
86.92  22.78% (Group 2), with no statistical significance
(P > 0.05). When the preoperative bone level was evalu-
ated in accordance with the bone defect at the secondary
surgical exposure within each group, the value of bone
height gain appeared to be statistically significant
(P < 0.05) (Table 3). In Group 1, 13 implants out of 18Figure 7 Illustration of the measurement reference points at
baseline. The same intrasurgical measurements are obtained
at implant exposure. AJZ abutment junction; MLZ maximum
vertical depth of the marginal bone to be vertically regener-
ated (ML-AJ); NL Z minimal vertical depth of the marginal
bone to be vertically regenerated (NL-AJ).
Table 3 The comparison between Group 1 and Group 2 in
mean bone level (mm) change around implants and % in
bone gain.
Group 1
(n Z 16)
Mean (SD)
Group 2
(n Z 13)
Mean (SD)
Sig*
Bone defect baselinea 2.38 (0.28)* 2.58 (0.34)* d
Bone defect at
surgical exposureb
0.19 (0.11)* 0.23 (0.11)* d
Bone level changec 2.19 (0.32) 2.35 (0.40) d
Bone gain (%)d 89.06 (27.33) 86.92 (22.78) d
Sig** * *
* Independent T-test (a,c), Mann-Whitney U test (b,d),
P > 0.05.
** Wilcoxon signed-rank test, P < 0.05.
Comparative analysis of guided bone regeneration 285implants (81%) showed completely filled regenerated bone
at bony defected sites. Whereas, bony defects around 9
implants out of 14 implants (64%) were completely filled
with regenerated bone in Group 2. The average primary
stability ISQ values were 63.64  11.81 in Group 1 and
65.53  8.14 in Group 2. The average secondary stability
ISQ values were 78.38  6.85 in Group 1 and 76.15  7.08 in
Group 2. There was no statistically significant difference
between the two groups in these values (P > 0.05).
Each group had a single case of a postoperative
complication. In Group 1, a 40-year-old male patient had
postoperative wound opening in the region of posterior
mandible. With conservative management including daily
dressing and strict oral hygiene care, the wound healed
with no infection. The preoperative bone level (baseline) in
this patient was 2 mm and the bone defect at re-entry
appeared to be 1 mm, leading to 50% of bone gain. In Group
2, a 47-year-old male patient, presented with an implant in
the maxillary premolar region complained of intermittent
pain from the area, however, without any clinical signs of
infection. Owing to the failure of osseointegration observed
at the second surgery following 3 months of healing of this
patient, the implant fixture was extracted and replaced
with a fixture of bigger diameter, with additional bone graft
procedures. However, the statistical calculations took
place excluding the values from this patient.Discussion
This study evaluated the amount of bone regeneration
following GBR using AutoBT with and without membrane.
Membranes used in GBR have known to prevent interfer-
ence factors to bone regeneration process such as ingrowth
of surrounding soft tissue cells and stress, leading to se-
lective bone cell growth.1 Additionally, reports showed
that the use of membrane was one of the positive factors
in enhancement of long-term implant prognosis and
esthetics.8
However, other studies reported that the use of a
membrane could increase the frequency of wound opening.
The resultant early exposure of the membrane may lead to
reduction in the amount of peri-implant tissue regenerated
jeopardizing bone regeneration around implants up to80%.9e11 Gotfrendsen et al reported that following imme-
diate implant placements at total of 32 sites, e-PTFE
membranes were used at 16 sites resulting in exposure at
61% of the sites, whereas in the 16 sites without the
membrane, only 19% sites had wound opening. They also
reported bone regeneration was significantly jeopardized
when the exposed membrane was not removed.12 In the
reports of implant placement with simultaneous GBR,
Nowzari et al experienced 47% of membrane exposure
during the 9-month healing period, and Becker et al
observed 41% of e-PTFE membrane exposure and infec-
tion.10,13 In such early exposure of resorbable membrane,
the membrane can be prematurely resorbed leading to the
loss of bone graft material and the possible isolation be-
tween the graft material and the recipient bed.14,15 In the
present study, there was a single case from Group 1 that
had wound opening leading to membrane exposure. After
conservative care on the wound site, no further infection
was observed around the exposure.
A few authors claimed that use of membrane rather in-
terferes with microvasular circulation leading to a delay in
healing of mucoperiosteal flap.16 In the animal study con-
ducted by Aaboe et al, a few sites of GBR using bovine
xenograft material and membrane showed resorption in
regenerated bone immediately below the membranes. It
supported consequential possibilities of the byproducts
leading to chemotaxis of osteoclasts thereby resulting in
further bone resorption.17 Further, they reported that for
the buccal dehiscence defects, the cohorts of GBR without
the membrane showed greater bone gain than the cohorts
with the membrane.18
Some studies, however, showed results that there is no
difference in use of membrane. Yet other factors, such as
proper healing period, healthy periosteum, and good oral
hygiene played important roles in bone regeneration after
GBR. Rasmusson et al reported that there was no difference
in implant stability and bone regeneration between the
groups of with and without membrane following implant
placement.19 Also, they added that the use of membrane
did not enhance revascularization within the graft mate-
rial.19 Lindhe et al presented that periosteal flap elevated
carefully may function as membrane and nourish the graf-
ted site with growth factors.3 However, Weng et al claimed
that the periosteum has a low potential for bone regener-
ation and that it does not contribute to new bone forma-
tion.20 With the vulnerability of the periosteum during the
surgery and due to its resilience, some authors report that
the periosteum may not fully function to maintain the
space for bone regeneration.21
In the present study, there were 13 cases (81%) of 100%
bone regeneration in Group 1, whereas Group 2 had only 9
cases (64%) of complete bone regeneration. These pre-
sented results may attribute to the factors leading to
instability of the grafted areas such as muscle attachment,
postsurgical pressure to the flap, and palatal vault height.
Although the periosteum is known to have many potential
regenerative functions, it is not so rigid that space main-
tenance and resistance to stress can be challenging.
Moreover, there is a high chance of intraoperative perios-
teum damage. It is at times inevitable to damage the
periosteum when raising the flap and giving relieving in-
cisions to achieve primary closure. Efforts need to be
286 J.-Y. Lee et alpracticed to minimize periosteal damage through giving
clean incision and raising the flap carefully, and when the
membrane is used it is necessary to minimize the exposure
by careful pre-surgical planning and placing incision at the
optimal location.8
Failure of osseointegration was observed in a patient of
Group 2 where no membrane was used. The 47-year-old
male patient was a diabetic under control and a heavy
smoker (30 cigarettes per daily). An implant fixture CMI
(length: 10 mm, diameter: 4.5 mm) was placed in the
maxillary premolar area of the patient. The premolar tooth
was extracted owing to continuous pain and mobility
(Grade III) even after treatment of the periapical lesion
with apicoectomy and periapical curettage followed by
grafting with demineralized freeze-dried bone. An implant
fixture was placed with simultaneous GBR 1 month after the
extraction. The average vertical bone defect height was
4 mm and the primary ISQ value was 62. There was no
clinical sign of postoperative complications such as abscess,
however, the patient complained of intermittent pain. At
the time of second surgery following 3 months of healing,
the failure of osseointegration was observed and the
implant fixture was removed. A new fixture of greater
diameter was placed with GBR. In this patient, persistent
periapical lesion, guarded periodontal condition, and sub-
optimal bone quality, along with the patient’s smoking
status, were thought to be the factors leading to the failure
of osseointegration.
The present study draws some limitations. The study
included limited observation period after GBR with limited
number of sample size. Moreover, the implant fixture types
were not standardized to all patients. Patient selection was
needed to be more controlled for acute evaluation despite
included patients with systemic diseases were controlled
and received approval from their physicians for dental
surgeries. Age calibration between two groups was needed
as well. However, there are only few studies that employed
the use of AutoBT. Therefore, the present study maybe
considered being significant in evaluating the clinical re-
sults at the time of secondary surgery after healing periods
of GBR using AutoBT with and without membrane.
Within the limitations of this study, there was no statis-
tically significant difference between the two groups of with
and without membrane in pre- and postoperative reduction
of bone defect height, bone level change, and bone gain (%).
Based on the results of the present study, we can carefully
conclude that AutoBT can be an effective bone grafting
material in GBR regardless in use of membranes.
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